{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:09:56Z","timestamp":1788458996324,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neo.2024.101075","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T18:20:12Z","timestamp":1729534812000},"page":"101075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["RRM2 inhibition alters cell cycle through ATM\/Rb\/E2F1 pathway in atypical teratoid rhabdoid tumor"],"prefix":"10.1016","volume":"58","author":[{"given":"Le Hien","family":"Giang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1887-9768","authenticated-orcid":false,"given":"Kuo-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing-Shung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Duy","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hsu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shian-Ying","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Tong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-2094","authenticated-orcid":false,"given":"Che-Chang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.neo.2024.101075_bib0001","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2004.07.073","article-title":"Central nervous system atypical teratoid\/rhabdoid tumor: results of therapy in children enrolled in a registry","volume":"22","author":"Hilden","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0002","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/neuonc\/nov264","article-title":"Atypical teratoid\/rhabdoid tumors-current concepts, advances in biology, and potential future therapies","volume":"18","author":"Fruhwald","year":"2016","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.neo.2024.101075_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100880","article-title":"Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor","volume":"37","author":"Alva","year":"2023","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.neo.2024.101075_bib0004","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.neo.2024.101075_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm2351","article-title":"Regulation of DNA repair throughout the cell cycle","volume":"9","author":"Branzei","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.neo.2024.101075_bib0006","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.cdd.4401130","article-title":"Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe","volume":"9","author":"Castedo","year":"2002","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0007","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2024.101075_bib0008","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.neo.2024.101075_bib0009","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.celrep.2016.04.036","article-title":"Sustained E2F-Dependent transcription is a key mechanism to prevent replication-stress-induced DNA damage","volume":"15","author":"Bertoli","year":"2016","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.neo.2024.101075_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108449","article-title":"Excessive E2F transcription in single cancer cells precludes transient cell-cycle exit after DNA damage","volume":"33","author":"Segeren","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.neo.2024.101075_bib0011","first-page":"1","article-title":"E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors","volume":"51","author":"Choi","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neo.2024.101075_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-biochem-013118-111843","article-title":"Ribonucleotide reductases: structure, chemistry, and metabolism suggest new therapeutic targets","volume":"89","author":"Greene","year":"2020","journal-title":"Annu. Rev. Biochem."},{"issue":"16","key":"10.1016\/j.neo.2024.101075_bib0013","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"issue":"28","key":"10.1016\/j.neo.2024.101075_bib0014","doi-asserted-by":"crossref","first-page":"eabn1382","DOI":"10.1126\/sciadv.abn1382","article-title":"RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition","volume":"8","author":"Nunes","year":"2022","journal-title":"Sci. Adv."},{"issue":"14","key":"10.1016\/j.neo.2024.101075_bib0015","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","article-title":"A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)","volume":"25","author":"Mazzu","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.neo.2024.101075_bib0016","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1074\/jbc.M312482200","article-title":"S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region","volume":"279","author":"Chabes","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.neo.2024.101075_bib0017","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/MCB.15.8.4215","article-title":"Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1\/S-regulatory genes","volume":"15","author":"DeGregori","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.neo.2024.101075_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s13046-023-02911-x","article-title":"Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor","volume":"42","author":"Giang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2024.101075_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030752","article-title":"Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical Teratoid\/Rhabdoid Tumors","volume":"12","author":"Tran","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.neo.2024.101075_bib0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc2399","article-title":"Cellular mechanisms of tumour suppression by the retinoblastoma gene","volume":"8","author":"Burkhart","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060845","article-title":"ATM: main features, signaling pathways, and its diverse roles in DNA damage response, tumor suppression, and cancer development","volume":"12","author":"Phan","year":"2021","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.neo.2024.101075_bib0022","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1582-4934.2010.01145.x","article-title":"The roles of p27(Kip1) and DNA damage signalling in the chemotherapy-induced delayed cell cycle checkpoint","volume":"14","author":"Liontos","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"19","key":"10.1016\/j.neo.2024.101075_bib0023","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1073\/pnas.190030497","article-title":"Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro","volume":"97","author":"Matsuoka","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6830","key":"10.1016\/j.neo.2024.101075_bib0024","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","article-title":"The ATM\u2013Chk2\u2013Cdc25A checkpoint pathway guards against radioresistant DNA synthesis","volume":"410","author":"Falck","year":"2001","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neo.2024.101075_bib0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35036406","article-title":"Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1","volume":"2","author":"Melchionna","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0026","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2024.101075_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-020-03639-w","article-title":"Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics","volume":"150","author":"Nesvick","year":"2020","journal-title":"J. Neurooncol."},{"issue":"7","key":"10.1016\/j.neo.2024.101075_bib0028","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/pbc.24481","article-title":"Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes","volume":"60","author":"Birks","year":"2013","journal-title":"Pediatr. Blood. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2024.101075_bib0029","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s12031-020-01587-8","article-title":"Identification of hub genes in atypical teratoid\/rhabdoid tumor by bioinformatics analyses","volume":"70","author":"Pan","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neo.2024.101075_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrm714","article-title":"Sibling rivalry in the E2F family","volume":"3","author":"Trimarchi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neo.2024.101075_bib0031","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"4-5","key":"10.1016\/j.neo.2024.101075_bib0032","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drup.2010.06.001","article-title":"Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance","volume":"13","author":"Engelmann","year":"2010","journal-title":"Drug Resist. Updat."},{"issue":"12","key":"10.1016\/j.neo.2024.101075_bib0033","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","article-title":"Cellular functions of the protein kinase ATM and their relevance to human disease","volume":"22","author":"Lee","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6922","key":"10.1016\/j.neo.2024.101075_bib0034","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neo.2024.101075_bib0035","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s12276-022-00862-5","article-title":"Transcriptional regulation and chromatin dynamics at DNA double-strand breaks","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"21","key":"10.1016\/j.neo.2024.101075_bib0036","first-page":"5934","article-title":"Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation","volume":"60","author":"Ahn","year":"2000","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jmcb\/mju045","article-title":"CHK2 kinase in the DNA damage response and beyond","volume":"6","author":"Zannini","year":"2014","journal-title":"J. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.neo.2024.101075_bib0038","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrm3640","article-title":"Phospho-Ser\/Thr-binding domains: navigating the cell cycle and DNA damage response","volume":"14","author":"Reinhardt","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.neo.2024.101075_bib0039","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ncb974","article-title":"Chk2 activates E2F-1 in response to DNA damage","volume":"5","author":"Stevens","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.neo.2024.101075_bib0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.neo.2024.101075_bib0041","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1101\/gad.8.13.1514","article-title":"Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression","volume":"8","author":"Johnson","year":"1994","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.neo.2024.101075_bib0042","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tibs.2004.06.006","article-title":"E2F target genes: unraveling the biology","volume":"29","author":"Bracken","year":"2004","journal-title":"Trends Biochem. Sci"},{"issue":"39","key":"10.1016\/j.neo.2024.101075_bib0043","doi-asserted-by":"crossref","first-page":"40511","DOI":"10.1074\/jbc.M404496200","article-title":"Aberrant regulation of survivin by the RB\/E2F family of proteins","volume":"279","author":"Jiang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0044","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/1535-7163.MCT-11-0024","article-title":"ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance","volume":"10","author":"Millour","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.neo.2024.101075_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1101\/gad.949802","article-title":"E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints","volume":"16","author":"Ren","year":"2002","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.neo.2024.101075_bib0046","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrc3539","article-title":"Forkhead box proteins: tuning forks for transcriptional harmony","volume":"13","author":"Lam","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.neo.2024.101075_bib0047","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41580-023-00593-z","article-title":"Principles and dynamics of spindle assembly checkpoint signalling","volume":"24","author":"McAinsh","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.neo.2024.101075_bib0048","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","article-title":"Human topoisomerases and their roles in genome stability and organization","volume":"23","author":"Pommier","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neo.2024.101075_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020371","article-title":"PBK\/TOPK: A Therapeutic Target Worthy of Attention","volume":"10","author":"Han","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.neo.2024.101075_bib0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrm.2016.27","article-title":"Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases","volume":"17","author":"Hydbring","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:48:48Z","timestamp":1730994528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S1476558624001167"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101075","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RRM2 inhibition alters cell cycle through ATM\/Rb\/E2F1 pathway in atypical teratoid rhabdoid tumor","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101075"}}